CCS Medical acquires Matria's direct-to-consumer biz
By HME News Staff
Updated Sun June 27, 2004
June 28, 2004
CLEARWATER, Fla. - CCS Medical, a leading direct-to-consumer provider of medical supplies, has reached an agreement to acquire Matria Pharmacy Lab and Supplies (MPLS), a division of Matria Healthcare.
CCS, a KRG Capital Partners portfolio company, provides diabetes self-management supplies and medications, and respiratory inhalation medications. Matria Healthcare is a leading provider of comprehensive disease management programs to health plans and employers.
The acquisition improves CCS Medical's market position and places the company in the top two or three home-delivery companies in the nation, by approximately doubling its customer base and revenue, the company reported in a release.
"The leadership team at CCS Medical is extremely excited about the synergistic combination of two of the leading companies in our market. The combination of Matria's market presence and CCS Medical's operational expertise built around world- class customer service will provide a powerful platform for future growth," said Joseph H. Capper, CEO of CCS Medical. "We are also enthusiastic to begin what we expect to be a long-term partnership with Matria Healthcare's disease management business."
Founded in 1996, KRG is a Denver-based private-equity buyout firm that currently manages over $860 million of committed equity capital and equity co-investments. KRG specializes in acquiring and recapitalizing unique and profitable middle-market companies.
Comments